Today: 21 January 2026
Subscribe
Browse Category

NASDAQ:RYAAY News 21 January 2026

Elon Musk-Ryanair feud turns into money talk as O’Leary invites investment

Elon Musk-Ryanair feud turns into money talk as O’Leary invites investment

Dublin, Jan 21, 2026, 11:01 GMT Ryanair’s chief executive Michael O’Leary said on Wednesday he would welcome an investment from Elon Musk, noting that a week of public back-and-forth has boosted bookings by 2% to 3%. “We’re a publicly owned company,” O’Leary told reporters in Dublin. (Reuters) The remarks come as the exchange on X, the platform once called Twitter,…
21 January 2026
····

Stock Market Today

  • Tempus AI Hits $1.1B Contracts and Positive EBITDA in 2025; Industry Peers Expand
    January 21, 2026, 9:47 AM EST. Tempus AI, Inc. (TEM) surpassed $1.1 billion in Total Contract Value by end-2025, partnering with over 70 pharma giants like AstraZeneca and Pfizer. It posted its first positive adjusted EBITDA of $1.5 million in Q3 2025, signaling financial progress. The company's AI platform underpins nearly 1,500 research projects, facilitating drug discovery with its multimodal datasets and diagnostic assays. Meanwhile, peer Hims & Hers (HIMS) doubled revenues with international expansions in Canada and Europe, acquiring platforms such as Livewell and ZAVA. Omnicell (OMCL) advanced healthcare automation with the Titan XT automated dispensing system and launched an innovation lab in Austin to optimize medication management. These developments highlight growing momentum and innovation across digital health and biopharma services in 2025.
Go toTop